Balchem announces role changes: Griffin to Corporate Development, Bengtsson adds Animal Nutrition oversight

BALCHEM CORP

Jonathan H. Griffin moves from SVP & GM, Animal Nutrition & Health to SVP, Corporate Development, effective immediately.
C. Martin Bengtsson, EVP & CFO, expands responsibilities to include leadership of Animal Nutrition & Health segment.
No material changes to compensatory arrangements for either officer as a result of these changes.
Effective date of both changes: March 27, 2024.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jonathan H. Griffin

Senior Vice President, Corporate Development

BCPC · BALCHEM CORP

Effective: 2024-03-27
Filed: March 29, 2024, 7:59 PM ET

On March 27, 2024, Balchem Corporation (the “Company”) announced that Jonathan H. Griffin, Senior Vice President and General Manager, Animal Nutrition and Health, would be moving into the role of Senior Vice President, Corporate Development, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan H. Griffin changed role as Senior Vice President, Corporate Development at BALCHEM CORP.

Action: moving into
Role: Senior Vice President, Corporate Development

Exact text from the filing

On March 27, 2024, Balchem Corporation (the “Company”) announced that Jonathan H. Griffin, Senior Vice President and General Manager, Animal Nutrition and Health, would be moving into the role of Senior Vice President, Corporate Development, effective immediately.

View on SEC.gov

BALCHEM CORP filing history →

Source: SEC EDGAR

accession 0001140361-24-016602

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.